HONOLULU — In response to allegations that Johnson & Johnson marketed Risperdal for unapproved uses, a settlement has been reached between the drug company and federal government with the Hawaiian Attorney General announcing that the state will receive $1.4 million of Johnson & Johnson’s payment.
The Hawaii News reported that the total settlement is said to total up to $1.2 billion in restitution and penalties. Additionally, Johnson & Johnson subsidiary Janssen Pharmaceuticals will plead guilty in Federal Court for illegally marketing its drugs to vulnerable consumers.
In addition to the $1.4 million Hawaii will receive from Johnson & Johnson, the state will also receive an additional $1.45 million from the Federal Government. This payment will come due to the governments role in Hawaii’s Medicaid Program.
The case against Johnson & Johnson was filed in Pennsylvanian Federal Court with Hawaii’s Department of the Attorney General and other staff working with the government to prosecute the drug giant.
A whistle blower who initially brought light to the violations will also be rewarded a share of the recovery.
Hawaii received an additional 10% of recovery due to an amendment to the Hawaii False Claims Act which will remain in effect for all future False Claims Act cases.
Our No-Fee Promise on Risperdal Cases
You can afford to have our great team of Risperdal lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a Risperdal settlement
- Phone calls are always free
Start Your Risperdal Lawsuit Claim
- Submit the Free Case Review Box on this page, or
- Call (866) 280-4722 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have claim, we will start immediately.
WARNING: There are strict time deadlines for filing Risperdal lawsuit claims.